TMCI
TMCI
NASDAQ · Health Care

Treace Medical Concepts Inc

$2.26
+0.22 (+10.78%)
As of Feb 8, 2:08 PM ET ·
Analyst Consensus
Sell
11
Analysts
Moderate
Coverage
Buy 1 9%
Hold 6 55%
Sell 4 36%
Price Target
Analyst Price Target +1,823.0% upside
Low Target $30.07
Average Target $43.46
High Target $50.98
Current Price $2.26
Current
$2.26
Target
$43.46
$30.07 $43.46 avg $50.98
Scenario Analysis
Bear Case
$30.07
1,230.5%
Low target
Base Case
$43.46
+1,823.0%
Avg target
Bull Case
$50.98
+2,155.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$54.14
-95.8% from high
52-Week Low
$25.66
+-91.2% from low
Target vs 52W High
$43.46
-19.7% vs high
Next Earnings Report
Feb 26, 2026 · After Market Close
9d
until earnings
EPS Est: $-0.15
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%